NASDAQ: ATHEAlterity Therapeutics Ltd Stock Ownership - Who owns Alterity Therapeutics?
Insider buying vs selling
Have Alterity Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ATHE insiders and whales buy or sell their stock.
ATHE Shareholders
What type of owners hold Alterity Therapeutics Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| David Allen Stamler | 0.11% | 11,827,570 | $53.16M | Insider |
| Lawrence Bernard Gozlan | 0.04% | 4,545,455 | $20.43M | Insider |
| Peter Ashley Marks | 0.02% | 1,818,182 | $8.17M | Insider |
| Niven Abby Sarah MacNish | 0.00% | 454,545 | $2.04M | Insider |
| Twin Lakes Capital Management LLC | 0.00% | 139,258 | $625.96k | Institution |
| Hb Wealth Management LLC | 0.00% | 58,460 | $262.78k | Institution |
| Morgan Stanley | 0.00% | 58,382 | $262.43k | Institution |
| Greenleaf Trust | 0.00% | 32,000 | $143.84k | Institution |
| Citadel Advisors LLC | 0.00% | 20,077 | $90.25k | Institution |
| Bnp Paribas Financial Markets | 0.00% | 6,809 | $30.61k | Institution |
ATHE vs Biotech Stocks
Alterity Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.